After reaching a new historical high in ARB, Wintermute has transferred a total value of 5.7 million US dollars worth of ARB to CEX
According to Scopescan monitoring, Wintermute has transferred a total of $5.7 million worth of ARB to CEX after reaching a historical high in ARB.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Morgan Stanley raises CME Group price target to $337
Chip design software leader Synopsys seeks collaboration with Chinese large model laboratories

Former BioNTech executive leads Bambusa Therapeutics (BBTX.US) in sprint to Nasdaq, "boosting" eczema drug trials
Bambusa Therapeutics Inc. has filed for an initial public offering, planning to raise funds for clinical trials of treatments for eczema and other inflammatory diseases.